Literature DB >> 29702798

What Are the Challenges in Conducting Cost-of-Illness Studies?

Dan Greenberg1, Mohamed Izham B Mohamed Ibrahim2, Imre Boncz3.   

Abstract

Year:  2014        PMID： 29702798     DOI： 10.1016/j.vhri.2014.08.003

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN： 2212-1099


× No keyword cloud information.
  4 in total

1.  Identification of Health Expenditures Determinants: A Model to Manage the Economic Burden of Cardiovascular Disease.

Authors:  Fiorella Pia Salvatore; Alessia Spada; Francesca Fortunato; Demetris Vrontis; Mariantonietta Fiore
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

2.  The national economic burden of rare disease in the United States in 2019.

Authors:  Grace Yang; Inna Cintina; Anne Pariser; Elisabeth Oehrlein; Jamie Sullivan; Annie Kennedy
Journal:  Orphanet J Rare Dis       Date:  2022-04-12       Impact factor: 4.123

Review 3.  Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions.

Authors:  Fernanda S Tonin; Ignacio Aznar-Lou; Vasco M Pontinha; Roberto Pontarolo; Fernando Fernandez-Llimos
Journal:  Pharm Pract (Granada)       Date:  2021-02-22

4.  Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach.

Authors:  Rukiye Numanoğlu Tekin; Meltem Saygılı
Journal:  Eur J Breast Health       Date:  2019-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.